The Company actively began researching healthcare sector business opportunities recently but had not committed to a specific model or acquisition. Now, the Company’s current negotiations with Brava Health, Inc, represents a material shift in its strategic direction. Accordingly, although the Company’s prior disclosures noted a broad and non-exclusive search for healthcare sector opportunities—including potential targets outside the United States—the current focus on Brava Health, Inc. provides investors with an initial framework to assess the potential merits and risks of a transaction within the healthcare innovation sector. The Company believes that Brava Health, Inc. distinguishes itself by leveraging state-of-the-art artificial intelligence to fundamentally transform patient care delivery.